Breast Neoplasms: all 12,820 studies

Page 104 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.

• IL-6 and IL-8 Level of Blood and Pleural Effusion During Chemotherapy in Metastatic Breast CancerTerminatedNCT01543126
• Prophylactic Treatment of Sleep/Fatigue Before and During ChemotherapyWithdrawnNCT01542983Not applicable
• Evaluation of Nutrition and Metabolism in Breast Cancer PatientsWithdrawnNCT01542216Not applicable
• Impact of Body Weight on Pharmacokinetic Analysis of Doxorubicin + Cyclophosphamide in Breast CancerWithdrawnNCT01542203
• Cognitive Rehabilitation Group Intervention for Breast Cancer SurvivorsCompletedNCT01540955Phase 2
• Study of Neoadjuvant Docetaxel and Cyclophosphamide in Locally Advanced or Node Positive Primary Breast Cancer With Companion Pharmacokinetic and Pharmacogenomic AnalysesCompletedNCT01540110Phase 2
• Tumour Necrosis Factor Release in Locally Advanced Breast Cancer Patients Receiving Neoadjuvant DocetaxelWithdrawnNCT01539876Phase 1
• Trial of Neoadjuvant EndoTAG-1 in Combination With Paclitaxel in HER2-negative Breast CancerCompletedNCT01537536Phase 2
• S1200: Acupuncture, Sham Acupuncture, or Wait List for Joint Symptoms Related to Aromatase Inhibitors in Pts W/Early-Stage Breast CancerCompletedNCT01535066Not applicable
• Efficacy and Tolerability of Eribulin Plus Lapatinib in Patients With Metastatic Breast Cancer (E-VITA)TerminatedNCT01534455Phase 2
• Pilot Study of a Breast Cancer Vaccine Plus Poly-ICLC for Breast CancerTerminatedNCT01532960Phase 1
• Tobacco Dependence in Breast Cancer Patients Trial of Varenicline (Chantix)TerminatedNCT01532232
• BIBW 2992 (Afatinib) and VinorelbineTerminatedNCT01531764Phase 2
• Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast CancerCompletedNCT01530607Phase 3
• Salvage Chemotherapy of Vinorelbine Plus Oxaliplatin in Metastatic Triple-negative Breast Cancer:a Prospective TrialStatus unknownNCT01528826Phase 2
• Low Dose of Metronomic Cyclophosphamide and Capecitabine in Pretreated HER2-negative Metastatic Breast CancerStatus unknownNCT01526512Phase 2
• Docetaxel With or Without Metronomic Cyclophosphamide as First Line Chemotherapy in Metastatic Breast CancerStatus unknownNCT01526499Phase 2
• A Randomized Study of TH Versus THL in First Line Treatment of HER2-positive Metastatic Breast CancerCompletedNCT01526369Phase 3
• Breast Cancer Screening InterventionCompletedNCT01525264Not applicable
• Digital Breast Tomosynthesis Versus Digital Mammography: A National Multicenter TrialStatus unknownNCT01524029
• Persistent Pain After Breast Cancer Treatment (PPBCT) - Risk Factors and Pathophysiological MechanismsCompletedNCT01523132
• Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsCompletedNCT01522820Phase 1
• Etude Tomos- Apport de la Tomosynthèse Dans le Bilan d'Extension locorégional préthérapeutique d'Une Tumeur du Sein : Recherche de multicentricité Tomos Study- Contribution of Tomosynthesis In Locoregional Pretherapeutic Staging of a Breast Tumor: Multicentricity SearchTerminatedNCT01522300Phase 2
• Predictive Clinical and Biological Parameters in Breast CancerTerminatedNCT01521676Not applicable
• The Use of Bioimpedance to Determine Pre-Clinical Lymphedema in the Post-Operative Breast Cancer PatientStatus unknownNCT01521000Not applicable
• Study to Compare Vinorelbine In Combination With the mTOR Inhibitor Everolimus vs. Vinorelbin Monotherapy for Second-line Treatment in Advanced Breast CancerCompletedNCT01520103Phase 2
• Attention and Interpretation Modification (AIM) for Fear of Cancer Recurrence: An Intervention Development StudyActive, not recruitingNCT01517945
• Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer SubjectsCompletedNCT01516307Phase 2
• The Preoperative Health & Body StudyActive, not recruitingNCT01516190Not applicable
• S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast CancerCompletedNCT01515800Not applicable
• Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast CancerStatus unknownNCT01514565
• Relevance of T Lymphocytes Tumor Infiltrates CD8 and Foxp3 as Immune Prognostic Biomarker in Breast Cancer Treated by Neo Adjuvant ChemotherapyActive, not recruitingNCT01513408Not applicable
• Pharmacodynamic Study of BKM120 in Breast CancerCompletedNCT01513356Early Phase 1
• A Study of Trastuzumab Emtansine in Patients With HER2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic FunctionCompletedNCT01513083Phase 1
• Phase 1b/2 Study of U3-1287 in Combination With Trastuzumab Plus Paclitaxel in Newly Diagnosed Metastatic Breast Cancer (MBC)TerminatedNCT01512199Phase 1/2
• Efficacy of a Web-based Tailored Self-management ProgramCompletedNCT01512069Not applicable
• The Effects of Equivalent Weight Loss With or Without Exercise Training on Breast Cancer Risk (SHAPE-2)CompletedNCT01511276Not applicable
• The Involvement of Breast Cancer Patients During Oncological ConsultationsCompletedNCT01510964Not applicable
• The Memorial Sloan-Kettering Cancer Center (MSKCCCompletedNCT01509963
• Suction Drain Versus the Use of Adaptive Skin Sutures After Mastectomy ± Axillary Lymphadenectomy; a Prospective Randomised StudyStatus unknownNCT01509781Phase 3
• VEGF-targeted Fluorescent Tracer Imaging in Breast CancerCompletedNCT01508572Phase 1
• Conservative Surgery With or Without Axillary Lymphnode Removal in Treating Women With T1N0 Breast CancerCompletedNCT01508546Phase 3
• Lifestyle Intervention for High Risk Cancer SurvivorsCompletedNCT01508273Not applicable
• Weight Variation During Chemotherapy in Breast Cancer PatientsCompletedNCT01506466Not applicable
• Integrated Molecular Profiling in Advanced Cancers TrialActive, not recruitingNCT01505400
• Part II: Exercise in Hispanic Breast Cancer SurvivorsActive, not recruitingNCT01504789Not applicable
• Neoadjuvant Chemotherapy for Operable Premenopausal Breast Cancer PatientsStatus unknownNCT01503905Not applicable
• The Role of the Novel 99mTc-NC100692 Tracer in Patients at High Risk or Known Breast CancerStatus unknownNCT01503697
• Pregnant Women With a Breast Cancer Diagnosed Between 2000 and 2014CompletedNCT01503034
• Pre-Operative, Single-Dose Ipilimumab and/or Cryoablation in Early Stage/Resectable Breast CancerCompletedNCT01502592Phase 1
• Irinotecan/Capecitabine Versus Capecitabine in Patients Treated With A/T for HER2 Negative Metastatic Breast CancerStatus unknownNCT01501669Phase 3
• Epigenetic Testing for Breast Cancer Risk StratificationCompletedNCT01501656
• MINT I Multi- Institutional Neo-adjuvant Therapy MammaPrint Project ICompletedNCT01501487Phase 4
• Faslodex Specific Clinical Experience InvestigationCompletedNCT01501266
• A Prevention Trial in Subjects at High Risk for Breast CancerCompletedNCT01500577Phase 2
• Effect of Diet and Exercise in Breast Cancer SurvivorsCompletedNCT01498536Not applicable
• Memory Training Intervention for Breast Cancer SurvivorsCompletedNCT01497015Not applicable
• Cosmetic and Functional Outcomes After Breast Conserving SurgeryCompletedNCT01496001Not applicable
• The Myocet/Lapatinib Study. ICORG 10-03, V5TerminatedNCT01495884Phase 1/2
• Effect of a Tailored Program of Physical Activity and Nutritional Counseling on Fatigue Reduction in Breast Cancer Patients Receiving an Adjuvant TreatmentCompletedNCT01495650Phase 3
• Phase Ib/II Trial of BEZ235 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast CancerTerminatedNCT01495247Phase 1/2
• Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast CancerCompletedNCT01493310Phase 1
• Study of Etoposide in Treating Patients With Recurrent or Metastatic Breast CancerStatus unknownNCT01492556Phase 2
• Study of TS-1 as 2nd Line Treatment in Patients With Advanced Metastatic Breast CancerStatus unknownNCT01492543Phase 2
• Patient Preferences for Breast Reconstruction After MastectomyCompletedNCT01488357
• A Phase II Neo-adjuvant Study Assessing TCH (Docetaxel, Carboplatin and Trastuzumab) and TCHL (Docetaxel, Carboplatin, Trastuzumab and Lapatinib) in HER-2 Positive Breast Cancer Patients.CompletedNCT01485926Phase 2
• An Observational Study to Register the Incidence of Breast Cancer and Current Clinical Care Patterns in KenyaCompletedNCT01484483
• Neoadjuvant Paclitaxel Versus BIBF 1120 Priming Followed by BIBF 1120 Plus Paclitaxel in Early HER-2 Negative Breast Cancer With Proteomic and Dynamic Imaging CorrelatesCompletedNCT01484080Phase 1/2
• Effectiveness and Toxicity of Gemcitabine/Lobaplatin Versus Gemcitabine/Cisplatin as Second-line Treatment in Metastatic Breast CancerStatus unknownNCT01483300Phase 2
• Vascular and Cognitive Assessments in Patients With Breast Cancer Undergoing Chemotherapy After SurgeryCompletedNCT01483196Not applicable
• Impact of Weight Loss Interventions for Overweight Breast Cancer SurvivorsCompletedNCT01482702Not applicable
• Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid TumorsCompletedNCT01482156Phase 1
• Study of Vitamin D Supplementation Tailored to Vitamin D Deficiency in Breast Cancer PatientsCompletedNCT01480869Phase 3
• GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain MetastasesCompletedNCT01480583Phase 2
• Electrochemotherapy For The Treatment Of Breast Cancer That Has Spread to the SkinWithdrawnNCT01479946Phase 2
• Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer RecurrenceCompletedNCT01479244Phase 3
• Trastuzumab in Combination With AMG 479 in HER-2 Overexpressing MBC Progressing on TrastuzumabWithdrawnNCT01479179Phase 1/2
• NBRST: Prospective Neo-adjuvant REGISTRY TrialCompletedNCT01479101
• Trial of Neoadjuvant Endostar, Docetaxel and Epirubicin for Patients With Breast CancerStatus unknownNCT01479036Phase 3
• Omega-3 Fatty Acids in Preventing Joint Symptoms in Patients With Stage I-III Breast Cancer Receiving Anastrozole, Exemestane, or LetrozoleCompletedNCT01478477Not applicable
• Veliparib With Radiation Therapy in Patients With Inflammatory or Loco-regionally Recurrent Breast CancerCompletedNCT01477489Phase 1
• Modulation of Response to Hormonal Therapy With Lapatinib and/or Metformin in Patients With Metastatic Breast CancerTerminatedNCT01477060Phase 2
• Evaluation of Specific Biomarkers in Primary Invasive Breast CancerTerminatedNCT01476111
• Neuropsychologic and Electrophysiological Features of Cancer-Related Cognitive Side Effects in Racial and Ethnic Minority Breast Cancer PatientsTerminatedNCT01473680
• ZoNantax - Zolendronic Acid as Neoadjuvant Therapy Plus Anthracycline and Taxane in Locally Advanced Breast CancerCompletedNCT01472146Phase 2
• The Hurria Older PatiEnts (HOPE) With Breast Cancer StudyActive, not recruitingNCT01472094
• A Phase Ib/II Study of BEZ235 and Trastuzumab in Patients With HER2-positive Breast Cancer Who Failed Prior to TrastuzumabCompletedNCT01471847Phase 1
• The Treatment of Stage I and II Carcinoma of the Breast With Mastectomy and Axillary Dissection Versus Excisional Biopsy, Axillary Dissection, and Definitive IrradiationCompletedNCT01468883Phase 3
• Effects of a Supervised Progressive Resistance Training With Breast Cancer Patients During Adjuvant RadiotherapyCompletedNCT01468766Not applicable
• Real-Time Near-infrared (NIR) Mapping of Sentinel Lymph Nodes in Breast CancerCompletedNCT01468649Early Phase 1
• The Young Women's Breast Cancer StudyActive, not recruitingNCT01468246
• Defining the Triple Negative Breast Cancer Kinome Response to GSK1120212CompletedNCT01467310Early Phase 1
• Influence of the Superficial Inferior Epigastric System in Deep Inferior Epigastric Perforator (DIEP) FlapsStatus unknownNCT01464970Not applicable
• Post-marketing Surveillance for the Clinical Safety and Effectiveness of Eribulin Mesylate in Patients With Inoperable or Recurrent Breast Cancer (Study HAL01S)CompletedNCT01463891
• A Study of Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid TumorsStatus unknownNCT01462903Phase 1
• Intestine Bacteria and Breast Cancer RiskCompletedNCT01461070
• Evaluation of the Predictive and Prognostic Value of Germ-line Polymorphisms in Patients With Metastatic Breast CancerCompletedNCT01460186Not applicable
• Human Breast Tissue Bioavailability of Topically Applied LimoneneCompletedNCT01459172Phase 1
• Evaluation of Beauty Care Before Chemotherapy in Women With Breast CancerCompletedNCT01459003Phase 3
• Life Quality and Mental State in Patients With Breast CancerCompletedNCT01458457Phase 4

← Breast Neoplasms overview